Jing Yang
Houston Methodist(US)Nanjing University of Chinese Medicine(CN)The University of Texas MD Anderson Cancer Center(US)Methodist Hospital(US)Methodist Hospital(US)Science & Technology Park (Czechia)(CZ)Beijing Haidian Hospital(CN)Sichuan Normal University(CN)
Publications by Year
Research Areas
Multiple Myeloma Research and Treatments, Immunotherapy and Immune Responses, Immune Cell Function and Interaction, Lymphoma Diagnosis and Treatment, Monoclonal and Polyclonal Antibodies Research
Most-Cited Works
- → Targeted Gene Disruption Demonstrates That P-Selectin Glycoprotein Ligand 1 (Psgl-1) Is Required for P-Selectin–Mediated but Not E-Selectin–Mediated Neutrophil Rolling and Migration(1999)316 cited
- → The Biology of P-Selectin Glycoprotein Ligand-1: Its Role as a Selectin Counterreceptor in Leukocyte-Endothelial and Leukocyte-Platelet Interaction(1999)254 cited
- → P-Selectin Glycoprotein Ligand 1 (Psgl-1) Is a Physiological Ligand for E-Selectin in Mediating T Helper 1 Lymphocyte Migration(2000)154 cited
- → Tumor evasion of the immune system: inhibiting p38 MAPK signaling restores the function of dendritic cells in multiple myeloma(2005)106 cited
- → MicroRNA-451 regulates stemness of side population cells via PI3K/Akt/mTOR signaling pathway in multiple myeloma(2015)105 cited
- → Optimizing immunotherapy in multiple myeloma: restoring the function of patients' monocyte-derived dendritic cells by inhibiting p38 or activating MEK/ERK MAPK and neutralizing interleukin-6 in progenitor cells